WESTMINSTER, Calif., April 18, 2018 (GLOBE NEWSWIRE) — BioLargo, Inc. (OTCQB:BLGO), an innovator of sustainable science and technology and full-service environmental engineering company, announced today that its Canadian subsidiary has received a commitment of up to CA$235,000 for a pre-commercial pilot project for its Advanced Oxidation System (AOS) for on-site treatment of poultry processing wastewater at a potential client’s poultry processing facility. The funding will be provided by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), Canada’s premier industrial innovation assistance program for small and medium-sized enterprises (SMEs). With this support, BioLargo’s AOS has received approximately CA$500,000 in total contributions to date from the NRC IRAP. The pilot will demonstrate the AOS’ ability to disinfect and decontaminate water at high flow-rates, allowing for recycling, reuse, and/or safe water discharge. Moreover, continuous treatment and recycling of the processed water in this pilot project will allow for a comprehensive assessment of the long term economic advantage (both operating and capital costs) and conservation benefits of the AOS for both energy and water, in comparison with conventional wastewater treatment technologies. Ultimately, the company expects the results of this pilot will lay an important foundation for the technical and business case that convinces future customers to purchase the AOS.
This pilot project and the NRC IRAP funding that supports it represents an important milestone in the company’s efforts to develop and commercialize the AOS, its patented and innovative water treatment platform technology. The AOS is, in essence, the result of a marriage between advances in iodine electrochemistry and materials engineering of carbon compounds, and data suggest it could lead to substantial economic and water savings in multiple industries. A pilot project for the AOS, as with any technology, is crucial to prove its reliability to industry stakeholders as well the capital cost and operating costs of our technology at-scale. These data will be critical to pave the way for future market adoption.
BioLargo Water’s President Dr. Richard Smith commented on this news, “This contribution will allow BioLargo Water to move forward with a long-term pilot in wastewater treatment to validate its ability to meet reuse standards. The continued support from NRC IRAP indicates the potential of our technology and demonstrates the need for our AOS on the global market. We thank the Government of Canada and NRC IRAP for their support.”
BioLargo, Inc.’s President and CEO Dennis Calvert also commented, “This pre-commercial pilot is an important step toward commercial production of our flagship AOS product. Our engineering team is working with our Canadian researchers and industrial stakeholders to push this product toward client installations and sales. We are working with a facility that processes six to eight thousand chickens per week, and we believe this project will directly lead to significant water and money savings for this client, as well as help prove up our value proposition in real-world conditions. We expect to operate our AOS on-site for an extended period of time under real life operating conditions.”
As is true with all novel technologies, field testing is critical to evaluate and refine the data in support of durability, capital cost, operating cost, and extended performance metrics. Calvert commented, “We believe our AOS technology can help the food processing industry improve its water overall self-sufficiency, reduce wastewater disposal costs and improve its continued march to improve its commitment to sustainability. We also believe the deployment of the AOS will save this industry money and water, both long term and short term, and the data we will develop in this commercial pilot will help us validate those claims.”
About BioLargo, Inc.
BioLargo, Inc. is an innovative technology incubator and environmental engineering company driven by a mission to “make life better” by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We incubate disruptive technologies by providing the capital, support, and expertise to expedite them from “cradle” to “maturity” (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System “AOS”, a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.
Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo’s current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo’s Annual Report on Form 10-K.
Dennis Calvert President and CEO BioLargo, Inc. 949-643-9540 x2